Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia

被引：0
|
作者：
Ru Han
Peter San Martin
Nurilign Ahmed
Adriana Guzman-Holst
Ahmed Mohy
Thatiana Pinto
Bruna de Veras
Jorge A. Gomez
Gyneth Lourdes Bibera
Désirée A. M. van Oorschot
机构：
[1] GSK,
[2] GSK,undefined
[3] GSK,undefined
[4] GSK,undefined
[5] GSK,undefined
来源：
Infectious Diseases and Therapy | 2024年 / 13卷
关键词：
Herpes zoster; Public health impact; Postherpetic neuralgia; Recombinant zoster vaccine; Southeast Asia; HZ; PHN; RZV;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：761 / 778
页数：17
相关论文
共 50 条
  • [1] Modelling the Public Health Burden of Herpes Zoster and the Impact of Adjuvanted Recombinant Zoster Vaccine in Five Selected Countries in Southeast Asia
    Han, Ru
    San Martin, Peter
    Ahmed, Nurilign
    Guzman-Holst, Adriana
    Mohy, Ahmed
    Pinto, Thatiana
    de Veras, Bruna
    Gomez, Jorge A.
    Bibera, Gyneth Lourdes
    van Oorschot, Desiree A. M.
    [J]. INFECTIOUS DISEASES AND THERAPY, 2024, 13 (04) : 761 - 778
  • [2] Shingrix - An Adjuvanted, Recombinant Herpes Zoster Vaccine
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2017, 59 (1535): : 195 - 196
  • [3] MODELLING HERPES ZOSTERS BURDEN AND PUBLIC HEALTH IMPACT OF ADJUVANTED RECOMBINANT ZOSTER VACCINE AMONG ADULTS AGED $50 YEARS OLD IN SEVEN COUNTRIES IN CENTRAL AND SOUTH AMERICA
    Han, R.
    Guzman-Holst, A.
    Gomez, J.
    Naranjo, L.
    Rosales, T.
    van Oorschot, D.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S232 - S233
  • [4] Adjuvanted Recombinant Glycoprotein E Herpes Zoster Vaccine
    Levin, Myron J.
    Weinberg, Adriana
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 70 (07) : 1509 - 1515
  • [5] Shingrix: The New Adjuvanted Recombinant Herpes Zoster Vaccine
    James, Stephanie F.
    Chahine, Elias B.
    Sucher, Allana J.
    Hanna, Cassandra
    [J]. ANNALS OF PHARMACOTHERAPY, 2018, 52 (07) : 673 - 680
  • [6] Healthy ageing: Herpes zoster infection and the role of the adjuvanted recombinant zoster vaccine
    Curran, D.
    Doherty, T. M.
    Lecrenier, N.
    Breuer, T.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2022, 32
  • [7] PUBLIC HEALTH IMPACT OF INTRODUCING ADJUVANTED RECOMBINANT ZOSTER VACCINE INTO THE VACCINATION PROGRAMME IN THE UK
    Hunjan, M.
    Curran, D.
    Marijam, A.
    Schamroth, J.
    Vekria, Y.
    Giannelos, N.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S178 - S179
  • [8] Public health impact of recombinant zoster vaccine for prevention of herpes zoster in US adults immunocompromised due to cancer
    Curran, Desmond
    Patterson, Brandon J. J.
    Carrico, Justin
    Salem, Ahmed
    La, Elizabeth M. M.
    Lorenc, Stephane
    Hicks, Katherine A. A.
    Poston, Sara
    Carpenter, Christopher F. F.
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2023, 19 (01)
  • [9] Corneal Allograft Rejection Associated With Herpes Zoster Recombinant Adjuvanted Vaccine
    Matoba, Alice
    [J]. CORNEA, 2022, 41 (06) : 772 - 774
  • [10] COST-EFFECTIVENESS ANALYSIS OF VACCINATING AGAINST HERPES ZOSTER WITH ADJUVANTED RECOMBINANT ZOSTER VACCINE IN SWITZERLAND
    Nishimwe, M. L.
    Fischer, L.
    Kientsch, U.
    Giannelos, N.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S71 - S71
12345